ARCHIVES

Daily Aspirin May Reduce Risk By 20 Percent, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

RFA Available

January 15, 1999

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010

HHS To Determine Feasibility Of CHOP Evaluation

July 24, 1981

In Brief: Basic Science Center Funding Plan Clarified; Janice Feldman Leaves As Chief Of NIH Nursing

February 17, 1989